Letter to the Editor
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jul 14, 2024; 30(26): 3253-3256
Published online Jul 14, 2024. doi: 10.3748/wjg.v30.i26.3253
Mean nocturnal baseline impedance in gastro-esophageal reflux disease diagnosis: Should we strictly follow the Lyon 2 Consensus?
Theodoros A Voulgaris, Georgios P Karamanolis
Theodoros A Voulgaris, Georgios P Karamanolis, Department of Gastroenterology, School of Medicine, National and Kapodistrian University of Athens, Athens 11527, Greece
Co-first authors: Theodoros A Voulgaris and Georgios P Karamanolis.
Author contributions: Voulgaris TA and Karamanolis GP contributed equally to manuscript preparation. Voulgaris TA and Karamanolis GP contributed equally to this work as co-first authors.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Theodoros A Voulgaris, MD, PhD, Researcher, Department of Gastroenterology, School of Medicine, National and Kapodistrian University of Athens, Agiou Thoma 17, Athens 11527, Greece. thvoulgaris87@gmail.com
Received: April 14, 2024
Revised: May 27, 2024
Accepted: June 13, 2024
Published online: July 14, 2024
Processing time: 86 Days and 6.2 Hours
Abstract

Clinical practice guidelines drive clinical practice and clinicians rely to them when trying to answer their most common questions. One of the most important position papers in the field of gastro-esophageal reflux disease (GERD) is the one produced by the Lyon Consensus. Recently an updated second version has been released. Mean nocturnal baseline impedance (MNBI) was proposed by the first Consensus to act as supportive evidence for GERD diagnosis. Originally a cut-off of 2292 Ohms was proposed, a value revised in the second edition. The updated Consensus recommended that an MNBI < 1500 Ohms strongly suggests GERD while a value > 2500 Ohms can be used to refute GERD. The proposed cut-offs move in the correct direction by diminishing the original cut-off, nevertheless they arise from a study of normal subjects where cut-offs were provided by measuring the mean value ± 2SD and not in symptomatic patients. However, data exist that even symptomatic patients with inconclusive disease or reflux hypersensitivity (RH) show lower MNBI values in comparison to normal subjects or patients with functional heartburn (FH). Moreover, according to the data, MNBI, even among symptomatic patients, is affected by age and body mass index. Also, various studies have proposed different cut-offs by using receiver operating characteristic curve analysis even lower than the one proposed. Finally, no information is given for patients submitted to on-proton pump inhibitors pH-impedance studies even if new and extremely important data now exist. Therefore, even if MNBI is an extremely important tool when trying to approach patients with reflux symptoms and could distinguish conclusive GERD from RH or FH, its values should be interpreted with caution.

Keywords: Mean nocturnal baseline impedance, Gastro-esophageal reflux disease, Lyon 2 Consensus, pH-impedance, Diagnosis

Core Tip: Mean nocturnal baseline impedance (MNBI) values add significant strength to a pH-impedance study, can help the clinician identify the correct explanation for a patient’s symptoms and tailor the patient’s therapy. Specific MNBI cut-offs have been proposed by several studies for characterizing patients with reflux symptoms. However, caution should be taken before applying the proposed cut-offs by the Lyon 2 Consensus as patient age, body mass index and origin may affect MNBI values.